Precision BioSciences (STU:PBS0) Beta: 1.1737 (As of Jun. 27, 2026)


STU:PBS0 Precision BioSciences Inc STU:PBS0
43 GF Score
Price €6.06
GF Value €1.52
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Precision BioSciences Beta?

Precision BioSciences STU:PBS0 +2.54% 43 Beta is 1.1737 as of Jun. 27, 2026. GuruFocus rates STU:PBS0 with a GF Score™ of 43/100 and a GF Value™ of €1.52 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-27), Precision BioSciences's Beta is 1.1737.


Precision BioSciences  (STU:PBS0) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Precision BioSciences Beta Related Terms


Precision BioSciences Beta Historical Data

* Premium members only.

The historical data trend for Precision BioSciences's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Precision BioSciences Beta Chart

Precision BioSciences Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 -0.37

Precision BioSciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.76 1.86 2.47 -0.37 0.77

STU:PBS0 vs TLSA, EQ, MIST: Beta Comparison

For the Biotechnology subindustry, Precision BioSciences's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Precision BioSciences Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Precision BioSciences's Beta distribution charts can be found below:

* The bar in red indicates where Precision BioSciences's Beta falls into.


STU:PBS0
43GF Score
Precision BioSciences Inc STU:PBS0
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Precision BioSciences Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 1.1737 mean?
Precision BioSciences (STU:PBS0) has a Beta of 1.1737 as of Jun. 27, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Precision BioSciences and its competitors.
Is Precision BioSciences' Beta too high?
Precision BioSciences' current Beta is 1.1737. Overall, Precision BioSciences has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Precision BioSciences' Beta compare to TLSA and EQ?
Precision BioSciences' Beta of 1.1737 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Precision BioSciences and its competitors. Precision BioSciences's current Beta is 1.1737. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Precision BioSciences stock overvalued right now?
Based on GuruFocus' analysis, Precision BioSciences (STU:PBS0) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.52, compared to a current price of €6.06 — trading 298.7% above its estimated fair value. The current Beta is 1.1737. Precision BioSciences' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Precision BioSciences (STU:PBS0), the current Beta is 1.1737 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Precision BioSciences (STU:PBS0) Overvalued in 2026?

Based on GuruFocus' analysis, Precision BioSciences stock appears to be overvalued. The current stock price of €6.06 is trading 298.7% above its estimated GF Value™ of €1.52. GuruFocus considers Precision BioSciences to be Significantly Overvalued.

Key valuation signals for STU:PBS0:

  • Beta: 1.1737
  • GF Value™: €1.52 vs. price of €6.06 (298.7% above fair value)
  • GF Score™: 43/100 with 4 warning signs

No single metric tells the full story. See the STU:PBS0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Precision BioSciences Business Description

Other Exchanges DTIL:USA
Address 302 East Pettigrew Street, Dibrell Building, Suite A-100, Durham, NC, USA, 27701
Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).
43GF Score

Get the complete analysis for STU:PBS0

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.06
Price
€1.52
GF Value